EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

A COMPARATIVE EVALUATION OF OZONE AND PLATELET RICH FIBRIN INJECTION IN MANAGEMENT OF UNILATERAL ANTERIOR DISC DISPLACEMENT WITH REDUCTION IN TEMPOROMANDIBULAR JOINT: A RANDOMIZED CONTROL TRIAL

Dr. Abhinav Shekhar, Dr. Shivangi Pandey, Dr. Shitij Srivastava, Dr. Love Kumar Bhatia, Dr. Anshuman Chaturvedi, Dr. Abhishek Singh

Genetics and Molecular Research · 15.07.2026

DOI: 10.4238/vpfwgf86 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 15.07.2026. Verfasst von Dr. Abhinav Shekhar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Temporomandibular disorders (TMDs), particularly anterior disc displacement with reduction (ADDwR), are common intra-articular disorders associated with pain, joint sounds, and functional limitation of the temporomandibular joint (TMJ). Conventional treatment modalities often provide variable outcomes, creating a need for minimally invasive regenerative approaches. Injectable platelet-rich fibrin (i-PRF) and ozone therapy have gained attention due to their anti-inflammatory, analgesic, and regenerative properties.

Aim

To compare the efficacy of intra-articular injectable platelet-rich fibrin and ozone injections in the management of unilateral anterior disc displacement with reduction of the temporomandibular joint. Materials and Methods: This prospective randomized controlled clinical trial included 80 patients diagnosed with unilateral anterior disc displacement with reduction who were randomly divided into two groups of 40 patients each. Group I received a single intra-articular i-PRF injection, while Group II received intra-articular ozone injections (10 μg/mL) twice weekly for three weeks. All patients received occlusal splint therapy before intervention. Clinical parameters including pain intensity assessed using Visual Analog Scale (VAS), maximum inter-incisal opening, and lateral mandibular excursion were evaluated at baseline, 2 weeks, 3 months, and 6 months. Magnetic resonance imaging (MRI) was performed at baseline and after 12 months to evaluate regenerative changes.

Results

Both treatment modalities demonstrated significant improvements in pain reduction and mandibular function during follow-up. Ozone therapy showed significantly greater pain reduction at 3 and 6 months and demonstrated superior regenerative changes on MRI evaluation compared with i-PRF. Improvement in maximum inter-incisal opening and lateral mandibular excursion was observed in both groups without statistically significant intergroup differences.

Conclusion

Both i-PRF and ozone therapy were effective in managing unilateral ADDwR; however, ozone therapy demonstrated comparatively superior clinical and regenerative outcomes.

Zitieren

APA

Shekhar, D. A., Pandey, D. S., Srivastava, D. S., Bhatia, D. L. K., Chaturvedi, D. A., & Singh, D. A. (2026). A COMPARATIVE EVALUATION OF OZONE AND PLATELET RICH FIBRIN INJECTION IN MANAGEMENT OF UNILATERAL ANTERIOR DISC DISPLACEMENT WITH REDUCTION IN TEMPOROMANDIBULAR JOINT: A RANDOMIZED CONTROL TRIAL. Genetics and Molecular Research. https://doi.org/10.4238/vpfwgf86

Vancouver

Shekhar DA, Pandey DS, Srivastava DS, Bhatia DLK, Chaturvedi DA, Singh DA. A COMPARATIVE EVALUATION OF OZONE AND PLATELET RICH FIBRIN INJECTION IN MANAGEMENT OF UNILATERAL ANTERIOR DISC DISPLACEMENT WITH REDUCTION IN TEMPOROMANDIBULAR JOINT: A RANDOMIZED CONTROL TRIAL. Genetics and Molecular Research. 2026. doi:10.4238/vpfwgf86

BibTeX
@article{Shekhar2026,
  author = {Shekhar, Dr. Abhinav and Pandey, Dr. Shivangi and Srivastava, Dr. Shitij and Bhatia, Dr. Love Kumar and Chaturvedi, Dr. Anshuman and Singh, Dr. Abhishek},
  title = {A COMPARATIVE EVALUATION OF OZONE AND PLATELET RICH FIBRIN INJECTION IN MANAGEMENT OF UNILATERAL ANTERIOR DISC DISPLACEMENT WITH REDUCTION IN TEMPOROMANDIBULAR JOINT: A RANDOMIZED CONTROL TRIAL},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/vpfwgf86}
}
Kostenlos starten →